
India's PLI schemes drew ₹2.4 lakh crore in investment through March, with ₹35,354 crore in incentives disbursed. Pharma sector sales hit ₹3.64 lakh crore.
India's Production Linked Incentive (PLI) schemes, launched in 2020 across 14 sectors with a ₹1.91 lakh crore outlay, have drawn ₹2.4 lakh crore in actual investment through March 31, Minister of State for Commerce and Industry Jitin Prasada told the Rajya Sabha on Friday.
The government has disbursed ₹35,354 crore in incentives to beneficiaries so far. The schemes have generated production or sales of ₹22.66 lakh crore, exports of ₹15.2 lakh crore, and employment for 14.15 lakh people – 8.4 lakh of those direct jobs, according to Prasada's written reply.
The pharmaceuticals sector, one of the 14, recorded cumulative sales of ₹3.64 lakh crore under the program. It has enabled domestic manufacture of 1,931 pharmaceutical products, including 191 bulk drugs made in India for the first time, strengthening local production capabilities, Prasada said.
The PLI schemes aim to enhance manufacturing, attract investment, promote exports, and reduce import dependence. The government approved 892 applications across the sectors as of the March 31 deadline.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.